The landscape of diabetic management is rapidly evolving, and regenerative approaches are emerging as a especially innovative area of study. While existing protocols often focus on managing blood sugar levels and addressing complications, cell-based therapy holds the potential to correct the underlying root issues of Type-2 diabetic conditions. Inv